Skip to main content
NCBI home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1997 Apr;150(4):1433–1441.

Hair growth modulation by topical immunophilin ligands: induction of anagen, inhibition of massive catagen development, and relative protection from chemotherapy-induced alopecia.

M Maurer 1, B Handjiski 1, R Paus 1
PMCID: PMC1858177  PMID: 9094998

Abstract

Selected immunophilin ligands (IPLs) are not only potent immunosuppressants but also modulate hair growth. Their considerable side effects, however, justify at best topical applications of these drugs for the management of clinical hair growth disorders. Therefore, we have explored hair growth manipulation by topical cyclosporin A (CsA) and FK 506 in previously established murine models that mimic premature hair follicle regression (catagen) or chemotherapy-induced alopecia, two major pathomechanisms underlying human hair loss. We confirm that topical CsA and FK 506 induce active hair growth (anagen) in the back skin of C57BL/6 mice with all follicles in the resting stage (telogen) and show that both IPLs also inhibit massive, dexamethasone-induced, premature catagen development in these mice. Furthermore, we demonstrate that CsA and FK 506 provide relative protection from alopecia and follicle dystrophy induced by cyclophosphamide, possibly by favoring the dystrophic anagen pathway of follicle response to chemical damage. Although it remains to be established whether these IPLs exert the same effects on human hair follicles, our study provides proof of the principle that topical IPLs can act as potent manipulators of clinically relevant hair-cycling pathomechanisms. This strongly encourages one to explore the use of topical IPLs in the management of human hair growth disorders.

Full text

PDF
1433

Images in this article

1437Figure 2
on p.1437
1438Figure 3
on p.1438
1439Figure 6
on p.1439
1440Figure 9
on p.1440

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. CHASE H. B. Growth of the hair. Physiol Rev. 1954 Jan;34(1):113–126. doi: 10.1152/physrev.1954.34.1.113. [DOI] [PubMed] [Google Scholar]
  2. Hendey B., Klee C. B., Maxfield F. R. Inhibition of neutrophil chemokinesis on vitronectin by inhibitors of calcineurin. Science. 1992 Oct 9;258(5080):296–299. doi: 10.1126/science.1384129. [DOI] [PubMed] [Google Scholar]
  3. Iwabuchi T., Maruyama T., Sei Y., Adachi K. Effects of immunosuppressive peptidyl-prolyl cis-trans isomerase (PPIase) inhibitors, cyclosporin A, FK506, ascomycin and rapamycin, on hair growth initiation in mouse: immunosuppression is not required for new hair growth. J Dermatol Sci. 1995 Jan;9(1):64–69. doi: 10.1016/0923-1811(94)00351-e. [DOI] [PubMed] [Google Scholar]
  4. Jiang H., Yamamoto S., Kato R. Induction of anagen in telogen mouse skin by topical application of FK506, a potent immunosuppressant. J Invest Dermatol. 1995 Apr;104(4):523–525. doi: 10.1111/1523-1747.ep12606018. [DOI] [PubMed] [Google Scholar]
  5. Lawson M. A., Maxfield F. R. Ca(2+)- and calcineurin-dependent recycling of an integrin to the front of migrating neutrophils. Nature. 1995 Sep 7;377(6544):75–79. doi: 10.1038/377075a0. [DOI] [PubMed] [Google Scholar]
  6. Li L., Hoffman R. M. The feasibility of targeted selective gene therapy of the hair follicle. Nat Med. 1995 Jul;1(7):705–706. doi: 10.1038/nm0795-705. [DOI] [PubMed] [Google Scholar]
  7. Mulkey R. M., Endo S., Shenolikar S., Malenka R. C. Involvement of a calcineurin/inhibitor-1 phosphatase cascade in hippocampal long-term depression. Nature. 1994 Jun 9;369(6480):486–488. doi: 10.1038/369486a0. [DOI] [PubMed] [Google Scholar]
  8. Paus R., Böttge J. A., Henz B. M., Maurer M. Hair growth control by immunosuppression. Arch Dermatol Res. 1996 Jun;288(7):408–410. doi: 10.1007/BF02507112. [DOI] [PubMed] [Google Scholar]
  9. Paus R., Handjiski B., Czarnetzki B. M., Eichmüller S. A murine model for inducing and manipulating hair follicle regression (catagen): effects of dexamethasone and cyclosporin A. J Invest Dermatol. 1994 Aug;103(2):143–147. doi: 10.1111/1523-1747.ep12392542. [DOI] [PubMed] [Google Scholar]
  10. Paus R., Handjiski B., Eichmüller S., Czarnetzki B. M. Chemotherapy-induced alopecia in mice. Induction by cyclophosphamide, inhibition by cyclosporine A, and modulation by dexamethasone. Am J Pathol. 1994 Apr;144(4):719–734. [PMC free article] [PubMed] [Google Scholar]
  11. Paus R., Schilli M. B., Handjiski B., Menrad A., Henz B. M., Plonka P. Topical calcitriol enhances normal hair regrowth but does not prevent chemotherapy-induced alopecia in mice. Cancer Res. 1996 Oct 1;56(19):4438–4443. [PubMed] [Google Scholar]
  12. Paus R., Stenn K. S., Link R. E. Telogen skin contains an inhibitor of hair growth. Br J Dermatol. 1990 Jun;122(6):777–784. doi: 10.1111/j.1365-2133.1990.tb06266.x. [DOI] [PubMed] [Google Scholar]
  13. Paus R., Stenn K. S., Link R. E. The induction of anagen hair growth in telogen mouse skin by cyclosporine A administration. Lab Invest. 1989 Mar;60(3):365–369. [PubMed] [Google Scholar]
  14. Rao A. NF-ATp: a transcription factor required for the co-ordinate induction of several cytokine genes. Immunol Today. 1994 Jun;15(6):274–281. doi: 10.1016/0167-5699(94)90007-8. [DOI] [PubMed] [Google Scholar]
  15. STRAILE W. E., CHASE H. B., ARSENAULT C. Growth and differentiation of hair follicles between periods of activity and quiescence. J Exp Zool. 1961 Dec;148:205–221. doi: 10.1002/jez.1401480304. [DOI] [PubMed] [Google Scholar]
  16. Slominski A., Paus R., Costantino R. Differential expression and activity of melanogenesis-related proteins during induced hair growth in mice. J Invest Dermatol. 1991 Feb;96(2):172–179. doi: 10.1111/1523-1747.ep12460956. [DOI] [PubMed] [Google Scholar]
  17. Slominski A., Paus R. Melanogenesis is coupled to murine anagen: toward new concepts for the role of melanocytes and the regulation of melanogenesis in hair growth. J Invest Dermatol. 1993 Jul;101(1 Suppl):90S–97S. doi: 10.1111/1523-1747.ep12362991. [DOI] [PubMed] [Google Scholar]
  18. Slominski A., Paus R., Plonka P., Chakraborty A., Maurer M., Pruski D., Lukiewicz S. Melanogenesis during the anagen-catagen-telogen transformation of the murine hair cycle. J Invest Dermatol. 1994 Jun;102(6):862–869. doi: 10.1111/1523-1747.ep12382606. [DOI] [PubMed] [Google Scholar]
  19. Slominski A., Paus R., Plonka P., Handjiski B., Maurer M., Chakraborty A., Mihm M. C., Jr Pharmacological disruption of hair follicle pigmentation by cyclophosphamide as a model for studying the melanocyte response to and recovery from cytotoxic drug damage in situ. J Invest Dermatol. 1996 Jun;106(6):1203–1211. doi: 10.1111/1523-1747.ep12348479. [DOI] [PubMed] [Google Scholar]
  20. Snyder S. H., Sabatini D. M. Immunophilins and the nervous system. Nat Med. 1995 Jan;1(1):32–37. doi: 10.1038/nm0195-32. [DOI] [PubMed] [Google Scholar]
  21. Yamamoto S., Jiang H., Kato R. Stimulation of hair growth by topical application of FK506, a potent immunosuppressive agent. J Invest Dermatol. 1994 Feb;102(2):160–164. doi: 10.1111/1523-1747.ep12371755. [DOI] [PubMed] [Google Scholar]
  22. Yamamoto S., Kato R. Hair growth-stimulating effects of cyclosporin A and FK506, potent immunosuppressants. J Dermatol Sci. 1994 Jul;7 (Suppl):S47–S54. doi: 10.1016/0923-1811(94)90035-3. [DOI] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES